MOH
- Marketing authorisation holder: HALEON US HOLDINGS
- Status: likely_approved
Excedrin Extra Strength Pain Reliever (NSAID) regulatory status in Israel.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it.
HALEON US HOLDINGS holds the Israeli marketing authorisation.